Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Disease After Preeclampsia

NCT03949829 is registered in ClinicalTrials.gov with Klaus Fuglsang Kofoed as lead sponsor.

NCT NCT03949829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03949829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Disease After Preeclampsia
Lead sponsor
Klaus Fuglsang Kofoed
Phase
Observational
Overall status
Active, not recruiting
Start date
May 20, 2019
Completion date
June 30, 2031
Enrollment
921 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, heart disease in women, pre-eclampsia